Ontario Bioscience Innovation Organization Congratulates Ontario on the Appointment of Chief Health Innovation Strategist

A key role for putting Ontario’s Innovation Economy to work supporting a sustainable healthcare system


Toronto, Ontario, September 14, 2015 – Today, Ontario Bioscience Innovation Organization (OBIO®) released a statement congratulating the Government of Ontario on the appointment of William Charnetski as Ontario’s first Chief Health Innovation Strategist.

“OBIO congratulates Mr. Charnetski on his appointment to this pivotal role,” said Gail Garland, Chief Executive Officer of OBIO. “We look forward to supporting his efforts to catalyze adoption of innovative health technologies which strengthen the province’s capacity to deliver cost-effective, outcome-focused care for patients.”

The Ontario Health Innovation Council (OHIC) report was delivered to government in late 2014.  The report contains six recommendations to reduce barriers to innovation and to better support the use of health care technologies in Ontario.  In its 2015 Budget, the province committed to adopting all six of the council’s recommendations of which establishing an office of the Chief Health Innovation Strategist was the first recommendation. Other key recommendations include the establishment of a $20 million Health Technology Innovation Evaluation Fund and shifting to strategic, value-based procurement and creating incentives for innovation.

OBIO commends Minster Hoskins, Minister Moridi and Minister Orazietti for this appointment and their commitment to health innovation in Ontario.


About OBIO®

The Ontario Bioscience Innovation Organization (OBIO®) is a not-for-profit, membership-based organization engaged in the development of an integrated health innovation economy for Ontario that will become a leader in prviding health technology to the international marketplace. OBIO advances this goal through advocacy, promotion and strategic leadership and via collaborative partnerships with industry, academia, patients and government.


OBIO Contact

Gail Garland

President and Chief Executive Officer

gailgarland@obio.ca

416-848-6839

Previous
Previous

Ontario Bioscience Innovation Organization Announces a Call for Applications for the 2016 Capital Access Advisory Program

Next
Next

OBIO Congratulates and Welcomes Johnson & Johnson Innovation, JLABS to the Ontario Bioscience Ecosystem